News

Every month a laureate of the Charcot Fond 2018 presents him or herself... This month : Prof. Dr. Vincent van Pesch

The laureates of the Charcot Fund 2018 are known: a choice for concrete results, a focus on progressive MS and, as usual, support for innovative basic research.

For a long time, Belgium has been at the forefront of MS research. This excellence is also ensured thanks to the continuity of the support provided by the Charcot Fund (since 1987) but also thanks to the expertise of the scientific jury.

The Board of Directors of the Charcot Foundation pays tribute to Mr. Philippe Maystadt, Minister of State.

As an encouragement for the groundbreaking work provided by our researchers, the Fondation Charcot Stichting will increase its financial support in 2018 from 200,000 euros to 300,000 euros. Discover our Newsletter.

For the first time in the world, this new type of cell therapy will be tested in MS patients.

Great progress has been made in 30 years! We can now establish a diagnosis much faster and we can implement increasingly effective early treatment...

Congratulations to the 77 valiant runners of TEAM CHARCOT - 20 km of Brussels 2017! Thanks to our runners and their supporters, thanks to everyone who sponsored them. Thanks to our partners and volunteers. An exceptional experience for everyone thanks to you!

The Fondation Charcot team is preparing for an unforgettable experience. Experienced runners, beginners, patient families, and even researchers... all are ready to support research.

Register now for the 20 km of Brussels 2017 for the benefit of the Belgian Charcot Foundation and support scientific research in multiple sclerosis.

For 30 years, the Belgian Charcot Foundation has been raising funds and funding research in multiple sclerosis. On January 19, 2017, teams of Belgian researchers received more than 200,000 euros to fund innovative projects in the fight against this disease.

The knowledge acquired today will form the basis of the drugs of tomorrow, maybe even in many years... from the lab to the patient, how does that happen in practice?